Accreditation

LEARNER NOTIFICATION

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/ certification requirement.

Joint Accreditation Statement

Physicians
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Virginia Orthopedic Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163

Amedco LLC designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After Attending This Program You Should Be Able To

1. Integrate current basic science, translational and clinical research in orthopedics into the delivery of evidence-based, cost- effective orthopaedic care
2. Improve upon prevention and management of geriatric hip fractures
3. Better understand the advantages, disadvantages and optimal method of soft tissue balancing in total knee arthroplasty

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.